Elective Cardiac Surgery
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CytoSorbentsCytoSorb
CytoSorbentsCytoSorb
Clinical Trials (2)
Total enrollment: 238 patients across 2 trials
CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery
Start: Apr 2018Est. completion: Jan 2022186 patients
N/ATerminated
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
Start: Nov 2015Est. completion: Dec 201652 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space